Pfizer and BioNTech's Unsettling Alignment With the Chinese Communist Party: Dr. Naomi Wolf

2009: Pfizer opened research and development hubs in three Chinese cities; one of them was Wuhan.

2020: Pfizer partnered with BioNTech right as the pandemic was rolling out to acquire their mRNA vaccine technology for them to produce the mRNA vaccines.

March of 2020: BioNtech united with Fosun pharmaceuticals out of Shanghai, China. Fosun injected $100 million into its joint venture. BioNtech agreed to provide the patent technology, and Fosun agreed to build the factories.

2021 SEC Filing Statement: There was a completed 100% tech transfer from BioNTech to China (no mention of Fosun Pharmaceuticals).

"This is a global company with a hub in Wuhan and a strong alliance with the Chinese Communist Party and at least some of its regional research and development and distribution centers, with a joint venture sharing data."